[1]
M. Mahdavi, M. Kheirollahi, and V. Moreau, “In silico prediction discontinuous B cell epitope peptide vaccine against leishmaniasis”, Int Pharm Acta, vol. 1, no. 1, pp. 106–107, Mar. 2018.